Advanced prostatic carcinoma: pulmonary manifestations.

Area of Science:

• Oncology
• Radiology
• Pulmonary Medicine

Background:

• Prostate adenocarcinoma staging is critical for treatment planning.
• Pulmonary manifestations can occur in advanced prostate cancer.
• The role of chest radiography in evaluating these manifestations requires clarification.

Purpose of the Study:

• To evaluate the utility of standard chest radiography in identifying pulmonary manifestations of prostatic adenocarcinoma.
• To determine the frequency and causes of intrathoracic abnormalities in Stage D disease.
• To assess the diagnostic accuracy of chest radiography in differentiating metastases from other pulmonary processes.

Main Methods:

• Retrospective review of serial chest radiographs from 198 patients with Stage D prostatic adenocarcinoma.
• Analysis of pulmonary abnormalities including opacities, nodules, effusions, and adenopathy.
• Correlation of radiographic findings with clinical data and treatment protocols.

Main Results:

• 35% of patients exhibited intrathoracic abnormalities on chest radiography.
• Only 24% of abnormalities were attributable to intrathoracic metastases.
• Common findings included pleural effusions (22%), reticular opacities (16%), and pulmonary nodules (8%).
• Metastatic disease was the primary cause of adenopathy and nodular opacities, but non-metastatic causes were frequent for effusions and reticular opacities.
• Four patients had intrathoracic metastases without bone metastases.

Conclusions:

• Standard chest radiography is a valuable screening tool for pulmonary abnormalities in advanced prostate cancer.
• Clinical correlation is essential to accurately interpret radiographic findings and differentiate metastases from concomitant conditions.
• Chest radiography can detect intrathoracic metastases, even in the absence of bone metastases.